{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:20:31Z","timestamp":1787761231894,"version":"build-2784847793"},"reference-count":15,"publisher":"BMJ","issue":"11","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2019,10,21]]},"published-print":{"date-parts":[[2019,11]]},"abstract":"<jats:p>We present the case of a 43-year-old woman with generalised idiopathic inflammatory myopathy (IIM) with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) autoantibodies (Abs) that developed following recurrent focal myositis. Anti-HMGCR Abs are myositis-specific Abs that are associated with immune-mediated necrotising myopathy, a subtype of IIM that is characterised by relatively prominent and severe muscle involvement, generally necessitating multimodal immunosuppressant treatment. While earlier reports have described patients developing polymyositis following focal myositis, this is the first report to describe a patient developing IIM with anti-HMGCR Abs following focal myositis. Thus, clinicians should be aware of the possibility that focal myositis may develop into a generalised IIM and should instruct the patient and monitor the patient accordingly.<\/jats:p>","DOI":"10.1136\/bcr-2019-229787","type":"journal-article","created":{"date-parts":[[2019,11,2]],"date-time":"2019-11-02T10:09:21Z","timestamp":1572689361000},"page":"e229787","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Recurrent focal myositis developing into a generalised idiopathic inflammatory myopathy with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7565-1954","authenticated-orcid":false,"given":"Johan","family":"Lim","sequence":"first","affiliation":[{"name":"Neurology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leroy","family":"Ten Dam","sequence":"additional","affiliation":[{"name":"Neurology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A","family":"Baars","sequence":"additional","affiliation":[{"name":"Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneke J","family":"Van der Kooi","sequence":"additional","affiliation":[{"name":"Neurology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,11,2]]},"reference":[{"key":"2025082722053471000_12.11.e229787.1","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.nmd.2016.08.014","article-title":"Focal myositis: a review","volume":"26","author":"Devic","year":"2016","journal-title":"Neuromuscul Disord"},{"key":"2025082722053471000_12.11.e229787.2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pediatrneurol.2017.01.002","article-title":"Recurrent focal myositis in childhood: a case report and systematic review of the literature","volume":"71","author":"Milani","year":"2017","journal-title":"Pediatr Neurol"},{"key":"2025082722053471000_12.11.e229787.3","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1007\/s00415-014-7313-z","article-title":"Long-Term follow-up of 62 patients with myositis","volume":"261","author":"van de Vlekkert","year":"2014","journal-title":"J Neurol"},{"key":"2025082722053471000_12.11.e229787.4","doi-asserted-by":"crossref","first-page":"e1013","DOI":"10.1212\/WNL.0000000000005160","article-title":"Focal myositis: new insights on diagnosis and pathology","volume":"90","author":"Gallay","year":"2018","journal-title":"Neurology"},{"key":"2025082722053471000_12.11.e229787.5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/mus.21316","article-title":"Distal-symmetric focal inflammatory myopathy distinct from focal myositis and polymyositis","volume":"40","author":"Melzer","year":"2009","journal-title":"Muscle Nerve"},{"key":"2025082722053471000_12.11.e229787.6","first-page":"1414","article-title":"Focal myositis: a localized form of polymyositis?","volume":"20","author":"Flaisler","year":"1993","journal-title":"J Rheumatol"},{"key":"2025082722053471000_12.11.e229787.7","first-page":"531","article-title":"Localised nodular myositis: a clinical and pathological variant of polymyositis","volume":"46","author":"Cumming","year":"1977","journal-title":"Q J Med"},{"key":"2025082722053471000_12.11.e229787.8","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1097\/PAS.0b013e31819e63fe","article-title":"Focal myositis: a clinicopathologic study of 115 cases of an intramuscular mass-like reactive process","volume":"33","author":"Auerbach","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"2025082722053471000_12.11.e229787.9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3233\/JND-170282","article-title":"Anti-HMGCR myopathy","volume":"5","author":"Mohassel","year":"2018","journal-title":"J Neuromuscul Dis"},{"key":"2025082722053471000_12.11.e229787.10","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000513","article-title":"Seronegative patients form a distinctive subgroup of immune-mediated necrotizing myopathy","volume":"6","author":"Lim","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2025082722053471000_12.11.e229787.11","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1981.00510070073013"},{"key":"2025082722053471000_12.11.e229787.12","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2018.2598","article-title":"Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies","volume":"75","author":"Mariampillai","year":"2018","journal-title":"JAMA Neurol"},{"key":"2025082722053471000_12.11.e229787.13","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.61.3.316"},{"key":"2025082722053471000_12.11.e229787.14","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00296-014-3198-5","article-title":"Polymyositis, a very uncommon isolated disease: clinical and histological re-evaluation after long-term follow-up","volume":"35","author":"Vilela","year":"2015","journal-title":"Rheumatol Int"},{"key":"2025082722053471000_12.11.e229787.15","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.autrev.2016.07.023","article-title":"Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: a history of statins and experience from a large international multi-center study","volume":"15","author":"Musset","year":"2016","journal-title":"Autoimmun Rev"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2019-229787","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T05:05:45Z","timestamp":1756357545000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2019-229787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":15,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,11,2]]},"published-print":{"date-parts":[[2019,11]]}},"alternative-id":["10.1136\/bcr-2019-229787"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2019-229787","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11]]}}}